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Abstract
Introduction: Immune reconstitution inflammatory syndrome during anti-retroviral treatment of acquired
immunodeficiency syndrome (AIDS) -associated gastrointestinal Kaposi’s sarcoma has rarely been reported.
Case Presentation: A 36-year-old Asian Indian male, newly diagnosed with AIDS and treatment naïve, was started
on highly active antiretroviral therapy (HAART). He developed acute intestinal obstruction after four weeks of
therapy. A laparotomy was done with excision and adhesiolysis leading to relief of symptoms. A histology report
revealed the lesion to be Kaposi’s sarcoma. Our patient was diagnosed to be having immune reconstitution
inflammatory syndrome associated with AIDS-associated gastrointestinal limited Kaposi’s sarcoma, which presented
as acute intestinal obstruction. Our patient was treated with paclitaxel post-operatively and HAART was continued.
Our patient responded to therapy.
Conclusion: Immune reconstitution inflammatory syndrome involving Kaposi’s sarcoma may occur in HAART-naïve
individuals with AIDS-related Kaposi’s sarcoma. Gastrointestinal Kaposi’s sarcoma may present with sudden increase
in size or inflammation leading to acute intestinal obstruction. This does not indicate failure of HAART or a need
for changes in anti-retroviral regimen.
Introduction
Kaposi’s sarcoma (KS) remains the most common tumor
in individuals infected with human immunodeficiency
virus (HIV) and is associated with significant morbidity
and mortality. Highly active anti-retroviral therapy
(HAART) for acquired immunodeficiency syndrome
(AIDS) decreases the incidence of KS, prolongs the time
to treatment failure in KS, leads to resolution of indivi-
dual lesions, and also decreases KS herpes virus viral
load. Immune reconstitution inflammatory syndrome
(IRIS) is well recognized as a complication of using
HAART for treating AIDS, especially when associated
with mycobacterial, fungal or viral infection. Our case
demonstrates that KS can worsen during HAART-asso-
ciated increases in the cluster of differentiation 4 (CD4)
count and KS is an IRIS-associated disease. IRIS-KS may
be associated with significant complications. It is impor-
tant for clinicians to realize that KS-associated IRIS does
not indicate failure of HAART or a need for changes in
the anti-retroviral regimen. Instead, chemotherapy in
conjunction with HAART can effectively control the
symptoms of IRIS as well as resolve KS.
Case presentation
A 36-year-old Asian Indian male patient attended our
clinical immunology outpatient clinic with a fever of
two months duration and two episode of herpes zoster
in the last year. He also complained of significant weight
loss in the last three months. He had no history of
chronic cough or diarrhea. He was not a diabetic and
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not alcoholic. Our patient had a history of multiple
unprotected sexual exposure around eight years ago.
On clinical examination his vitals were normal. He
had a mild pallor and oral candidiasis. He had no signif-
icant lymphadenopathy or any cutaneous lesions. A sys-
temic examination revealed no significant abnormality.
Routine investigations were within normal limits. An
ultrasound of his abdomen revealed no abnormality. An
enzyme-linked immunosorbent assay (ELISA) for HIV-1
was positive and this was confirmed by western blot.
Serology for Hepatitis B and C was non-reactive. Our
patient’s CD4 count was 67/mm3. He was put on
HAART therapy consisting of nevirapine 30 mg twice a
day, lamuvidine 150 mg twice a day and zidovudine 300
mg twice a day.
After 12 days our patient came back with a complaint
of upper abdominal discomfort. An abdominal examina-
tion revealed mild epigastric tenderness, no organome-
galy and normal peristaltic sound. An ultrasound of his
abdomen was normal. He was presumed to be suffering
from gastrointestinal side-effects, which is very common
during initiation of HAART, and advised to take a pro-
ton pump inhibitor.
Our patient came back after another two weeks with
severe abdominal pain, vomiting and abdominal disten-
sion. On examination his abdomen was found to be dis-
tended with absent peristaltic sound. An ultrasound of
his abdomen was done and showed distended bowel
loops with an admixture of air and fluid suggestive of
acute intestinal obstruction. Routine investigations were
normal and his CD4 count was 356/mm3. We put our
patient on conservative management with fluids and
nasogastric suction. However there was no improvement
in 24 hours and our patient complained of increasing
pain. A surgical consultation was taken and an explora-
tory laparotomy was performed with universal precau-
tions. On exploration, small bowel loops were seen
matted with a minimal amount of ascites. Purple
colored patches, three in number, were seen on the ser-
osal surface of his small bowel. Three thick walled, pur-
ple colored rounded cystic lesions adherent to
surrounding bowel loops and omentum containing dirty
white fluids were seen on the small bowel mesentery.
The lesions had prominent veins over their surfaces
(Figures 1 and 2). The lesions were excised; adhesiolysis
was performed followed by peritoneal lavage with nor-
mal saline. The excised lesion was sent for
histopathology.
Our patient’s symptoms improved after surgery. He
was started on an oral diet after five days. The histologi-
cal examination of the excised lesion showed tortuous
blood vessels lined by a single layer of pleomorphic
endothelial cells with extra-vasation of red blood cells in
the stroma with spindle cells (Figure 3) suggestive of
KS. His CD4 count was repeated and was 476/mm3.
Our patient was started on paclitaxel (eight cycles of
100 mg/m2 intravenously over three hours every two
weeks) and the HAART was continued along with sup-
portive management. He responded well to treatment
and is doing well on follow-up.
Discussion
KS is a multi-focal neoplastic disease that originates
from the lymphatic endothelium, most frequently invol-
ving the skin. Also commonly involved are the mucous
membrane, lymph nodes, gastrointestinal system and
lungs. Lesions have been reported in virtually every
organ including the heart and central nervous system.
Human herpes virus-8 has been strongly implicated as a
co-factor in the pathogenesis of KS. In HIV-infected
patients, KS is an AIDS-defining illness.
Figure 1 Purple colored patches on the small bowel serosal
surface seen during laparotomy.
Figure 2 Purple colored rounded cystic lesions lined by
tortuous vessels seen on the small bowel mesentery during
laparotomy.
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Gastrointestinal involvement in KS is frequent in
patients with advanced HIV disease. In one series of KS,
gastrointestinal lesions were found in up to 51% of the
cases [1]. Most clinical series have underestimated the
overall incidence of luminal gastrointestinal involvement
with KS because intestinal lesions rarely lead to symp-
toms. In a prospective endoscopic evaluation of 50
AIDS patients with KS, gastrointestinal tract involve-
ment was present in almost all cases [2]. In another ser-
ies, gastrointestinal involvement was reported in 40% of
cases at initial diagnosis and up to 80% at autopsy.
Gastrointestinal involvement commonly occurs in
association with cutaneous lesions or lymph node invol-
vement, with gastrointestinal tract involvement alone
occurring in only 3.5% of cases [3]. The absence of skin
or lymph node KS, however, does not exclude the possi-
bility of gastrointestinal involvement [2]. Gastrointestinal
KS is mostly found in the stomach and duodenum with
jejunum, ileum or large bowel rarely being involved.
The biliary tract is also commonly involved. Lesions
appear either as macule, sub-mucosal growth or as
nodules [2]. Most of the lesions (80%) are clinically
silent with bleeding, protein-losing enteropathy, mal-
absorption and obstructive jaundice being the most
common presentation. Gastrointestinal obstruction has
also been rarely reported [2].
IRIS is an inflammatory reaction to an opportunistic
pathogen and/or tumor antigen that occurs early after
initiation of HAART in patients with AIDS and is tem-
porally related to an increase in the host’s CD4+ lym-
phocyte count [4]. IRIS is most frequently observed in
individuals with severe CD4+ T-cell depletion and is
believed to be due to reconstitution of immune
responses to a previously existing (but clinically occult
or previously treated) pathogen or tumor antigen, rather
than development of a new opportunistic infection or
progression of opportunistic infection due to treatment
failure. Our patient had AIDS and started on HAART
therapy. He was admitted with severe pain abdomen
after four weeks of HAART and diagnosed to be having
intestinal obstruction. An emergency laparotomy was
done which showed matted small bowel loops with pur-
ple colored patches and cysts with adhesions on the
small bowel serosal surface and mesentery. Adhesiolysis
and resection were done and the lesion sent for histo-
pathological examination, which showed it to be a case
of KS. Our patient had no features of KS during initia-
tion of HAART. An ultrasound of his abdomen was also
normal.
Initiation of HAART is usually associated with a
regression of KS. However in this case there was prob-
ably a rapid increase in the size of the KS lesion, causing
intestinal obstruction. Several features of this case sug-
gest that the worsening symptoms and clinical finding
represented IRIS rather than progressive KS. The rise in
his CD4 count and the temporal relationship of bowel
obstruction to HAART initiation also support the diag-
nosis of KS-IRIS.
Although KS is prevalent among HIV-1 infected per-
sons, IRIS during anti-retroviral treatment of AIDS-
associated KS has only been reported three times [5-7].
In one case, laryngeal obstruction occurred in a patient
with known KS shortly after initiation of HAART [5]. In
the second case, parotid gland KS developed in an indi-
vidual two years after initiation of HAART, despite
there being good CD4+ lymphocyte reconstitution and
virus suppression [6]. In the third case, rapidly progres-
sive KS lesions with lymphadenopathy and tissue swel-
ling occurred in a patient during anti-retroviral
treatment, despite an increased CD4+ lymphocyte count
and decreased HIV-1 level and KS-associated herpes
virus replication [8].
In a review of 5,832 patients with AIDS undergoing
HAART, Bower et al. identified 150 therapy-naïve
patients with a first presentation of KS and recorded
their clinic-pathologic features prospectively[9]. They
identified ten patients with IRIS-KS in the patient
cohort of HIV patients with KS who were started on
HAART.
This is a rare case of IRIS associated with AIDS-
related gastrointestinal limited KS, presenting as an
acute intestinal obstruction. It is likely that KS-asso-
ciated IRIS is more common than the literature reflects
due to limited awareness of this condition. It is impor-
tant for clinicians to realize that KS-associated IRIS does
Figure 3 Biopsy of excised lesion showing tortuous blood
vessels, proliferation of pleomorphic endothelial cells with
extra-vasation of red blood cells in stroma. (H&E stain, 400×).
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not indicate failure of HAART or a need for changes in
the anti-retroviral regimen. Instead, chemotherapy in
conjunction with HAART can effectively control the
symptoms of IRIS as well as resolve KS, especially when
KS-IRIS is severe or there is visceral involvement.
Conclusions
IRIS-KS may occur in HAAR- naïve individuals with
AIDS-related KS. Gastrointestinal KS may present with
a sudden increase in size leading to acute intestinal
obstruction. KS-associated IRIS does not indicate failure
of HAART or a need for changes in the anti-retroviral
regimen.
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